HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Breast cancer cells: Modulation by melatonin and the ubiquitin-proteasome system--a review.

Abstract
Melatonin inhibits human breast cancer cells stimulated with estrogen. This antiproliferative action depends on the presence of the estrogen receptor alpha (ERα) in the human MCF-7 cell line and is strictly dose-dependent. Since researchers concerned with melatonin and breast cancer have not considered the relevance of the ubiquitin-proteasome system to this research in this review we do so. The fact that the first breast cancer susceptibility gene to be identified, Brca1, functions as a ubiquitin ligase indicates that the ubiquitin-proteasome system has a role in regulating susceptibility to breast cancer. While mutations of this gene increase the incidence of breast cancer, the wild type gene suppresses estrogen-dependent transcriptional events relying on the estrogen receptor ERα. Three other ubiquitin ligases, SCF(Skp2), E6AP and APC, interact directly with ERα at the ERE and AP-1 promoters of ERα target genes. Melatonin, like proteasome inhibitors, decreases estrogen-induced gene transcription. Indeed, it has been reported that melatonin specifically inhibits estrogen-induced transcription mediated by ERα at the ERE and AP1 gene promoters. Herein, we present a model in which the inhibitory action of melatonin on MCF-7 cells is mediated, directly or indirectly, by the ubiquitin-proteasome system. In this model ERα, apoptotic proteins, and cell cycle proteins, all influenced by melatonin, are substrates of key ubiquitin ligases including SCF(Skp2), E6AP, and SCF(B-TrCP). Since dysfunction of the ubiquitin-proteasome system is a risk factor for breast cancer, this model provides a context in which to test the clinical potential, and limitations, of melatonin and proteasome inhibitors.
AuthorsJerry Vriend, Russel J Reiter
JournalMolecular and cellular endocrinology (Mol Cell Endocrinol) Vol. 417 Pg. 1-9 (Dec 05 2015) ISSN: 1872-8057 [Electronic] Ireland
PMID26363225 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • APC protein, human
  • Adenomatous Polyposis Coli Protein
  • BRCA1 Protein
  • BRCA1 protein, human
  • ESR1 protein, human
  • Estrogen Receptor alpha
  • S-Phase Kinase-Associated Proteins
  • UBE3A protein, human
  • Ubiquitin-Protein Ligases
  • Melatonin
Topics
  • Adenomatous Polyposis Coli Protein (genetics)
  • BRCA1 Protein (metabolism)
  • Breast Neoplasms (metabolism)
  • Cell Proliferation (drug effects)
  • Estrogen Receptor alpha (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • MCF-7 Cells
  • Melatonin (pharmacology)
  • S-Phase Kinase-Associated Proteins (genetics)
  • Transcription, Genetic (drug effects)
  • Ubiquitin-Protein Ligases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: